Innovex International (INVX) AI Stock Analysis

• Market Cap: $1.12B
• Dividend Yield: N/A
• Average Volume (3M): 369.42K
• Price to Earnings (P/E): 5.5
• Beta (1Y): 1.03
• Revenue Growth: 82.86%
• EPS Growth: N/A
• Country: US
• Employees: 2,683
• Sector: Energy
• Sector Strength: 51
• Industry: Oil & Gas Equipment & Services
• EPS (TTM): 0.28
• Shares Outstanding: 68,779,150
• 10 Day Avg. Volume: 340,905
• 30 Day Avg. Volume: 369,421
• PEG Ratio: 0.16
• Price to Book (P/B): 0.73
• Price to Sales (P/S): 1.05
• P/FCF Ratio: 8.70
• Enterprise Value/Market Cap: 0.99
• Enterprise Value/Revenue: 1.45
• Enterprise Value/Gross Profit: 4.42
• Enterprise Value/Ebitda: 6.30
• 1Y Price Target: $17.75
• Price Target Upside: 5.72% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 4

• Rating: 72 Outperform
• Price Target: $18.00 ▲(7.21% Upside)

Innovex International's strong financial performance and attractive valuation are the primary drivers of its stock score. While technical indicators show a neutral trend, the company's strategic initiatives and robust balance sheet provide a solid foundation. However, market uncertainties and international challenges pose risks that temper the overall score.

Innovex International Business Overview & Revenue Model

Company Description

Innovex International (INVX) is a global technology company specializing in the development and distribution of advanced solutions across various sectors, including telecommunications, healthcare, and industrial automation. The company focuses on delivering innovative products and services such as IoT devices, software solutions, and integrated systems that enhance operational efficiency and connectivity for businesses worldwide.

How the Company Makes Money

Innovex International generates revenue through multiple streams, primarily from the sale of hardware and software products tailored for specific industry applications. Key revenue streams include direct sales of IoT devices, licensing fees from proprietary software solutions, and ongoing maintenance and support services for their products. Additionally, Innovex has established strategic partnerships with major corporations in the telecommunications and healthcare sectors, enabling them to expand their market reach and drive sales through collaborative projects and joint ventures. The company also benefits from recurring revenue through subscription models for its software offerings, providing a stable income base as customers rely on continuous support and updates.

Innovex International Financial Statement Overview

Summary

Innovex International demonstrates strong financial health with robust revenue growth and profitability. The balance sheet is stable with low leverage, and cash flow generation is improving. However, there is room for improvement in operational cost management and cash conversion ratios.

Income Statement

Innovex International shows a strong revenue growth trajectory, with a significant increase in total revenue from 2023 to 2024. The gross profit margin improved, indicating better cost management. However, the EBIT margin declined, suggesting increased operational costs. The net profit margin is robust, reflecting strong profitability.

Balance Sheet

The company's balance sheet is solid, with a low debt-to-equity ratio indicating low leverage and financial stability. The equity ratio is strong, reflecting a healthy balance between equity and total assets. Return on equity is impressive, showcasing efficient use of shareholder funds. However, the increase in total liabilities needs monitoring.

Cash Flow

Innovex International's cash flow statement indicates a positive shift in free cash flow, showing significant growth. The operating cash flow to net income ratio is healthy, suggesting good cash generation relative to earnings. However, the free cash flow to net income ratio indicates room for improvement in converting earnings to cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	763.26M	660.80M	424.06M	467.19M	294.84M	364.97M
Gross Profit	251.17M	232.63M	115.41M	157.15M	87.40M	95.09M
EBITDA	176.23M	184.77M	129.93M	95.43M	33.59M	-29.04M
Net Income	127.32M	140.32M	73.93M	63.28M	9.85M	-30.77M
Balance Sheet
Total Assets	1.20B	1.20B	1.03B	436.29M	284.89M	1.15B
Cash, Cash Equivalents and Short-Term Investments	68.12M	73.28M	7.41M	8.42M	9.74M	345.95M
Total Debt	82.73M	91.07M	84.91M	81.40M	35.24M	1.25M
Total Liabilities	217.63M	239.33M	146.38M	185.01M	104.34M	109.64M
Stockholders Equity	978.38M	958.16M	328.92M	251.28M	180.55M	1.04B
Cash Flow
Free Cash Flow	57.34M	79.84M	-24.90M	-15.39M	-8.47M	-33.03M
Operating Cash Flow	79.85M	93.44M	75.86M	-5.81M	-2.02M	-21.09M
Investing Cash Flow	56.29M	78.44M	-79.81M	-37.52M	-22.06M	-5.63M
Financing Cash Flow	-87.73M	-103.07M	-124.00K	42.28M	10.05M	-25.18M

Innovex International Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 16.79
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For INVX, the sentiment is Positive. The current price of 16.79 is above the 20-day moving average (MA) of 16.43, above the 50-day MA of 16.16, and above the 200-day MA of 15.93, indicating a bullish trend. The MACD of 0.07 indicates Negative momentum. The RSI at 56.29 is Neutral, neither overbought nor oversold. The STOCH value of 64.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INVX.

Innovex International Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
XPRO	78 Outperform	$1.30B	18.48	4.78%	―	2.67%	―
INVX	72 Outperform	$1.12B	5.55	15.64%	―	82.86%	―
RES	68 Neutral	$966.30M	17.60	4.92%	3.65%	-2.74%	-54.52%
MRC	64 Neutral	$1.19B	41.18	5.66%	―	-9.81%	-124.43%
HLX	64 Neutral	$840.76M	17.63	3.27%	―	-8.19%	―
WTTR	59 Neutral	$977.40M	25.02	4.18%	3.53%	-2.46%	-44.11%
Sector *	54 Neutral	C$4.15B	0.97	16.40%	5.23%	10.45%	-57.37%

Innovex International Corporate Events

Innovex International Reports Q2 2025 Financial Results

On August 5, 2025, Innovex International announced its financial results for the second quarter of 2025, reporting revenue of $224 million, a 7% decrease from the previous quarter. Despite the revenue decline, the company maintained profitability with a net income of $15 million and strong free cash flow of $52 million. Innovex completed the acquisition of Citadel Casing Solutions, LLC, which is expected to drive organic growth and enhance its market position. The acquisition was valued at $70 million and was 8% accretive to Innovex’s EPS. The company also repurchased 624,531 shares of its stock and maintained a net cash balance sheet, allowing flexibility for future M&A opportunities.

The most recent analyst rating on (INVX) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Innovex International stock, see the INVX Stock Forecast page.

Innovex International Approves New Executive Incentive Plan

On May 30, 2025, Innovex International‘s Board of Directors approved new forms of restricted stock unit (RSU) and performance unit award agreements under its 2025 Long-Term Incentive Plan. These awards, which vest over three years, were granted to key executives and are designed to align their interests with company performance goals, potentially impacting shareholder returns and executive retention.

The most recent analyst rating on (INVX) stock is a Sell with a $13.00 price target. To see the full list of analyst forecasts on Innovex International stock, see the INVX Stock Forecast page.

Innovex International Holds Annual Stockholders Meeting

On May 14, 2025, Innovex International, Inc. held its Annual Meeting of Stockholders where several key proposals were approved. The stockholders approved the 2025 Long-Term Incentive Plan, which allows for the issuance of up to 5,000,000 shares of common stock, and an amendment to the company’s Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 200,000,000. Additionally, the election of directors, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and an advisory vote on executive compensation were also ratified. These decisions are expected to impact the company’s operations by expanding its capacity for stock issuance and strengthening its governance structure.

The most recent analyst rating on (INVX) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Innovex International stock, see the INVX Stock Forecast page.